Stratos Wealth Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
Stratos Wealth Advisors's GILD Position: Q1 2026 in Review
Stratos Wealth Advisors reduced its Gilead Sciences (GILD) stake by 3% in Q1 2026, selling an estimated $7K and leaving 1,616 shares worth $225K. The position accounts for 0.01% of the portfolio, ranked #557.
Stratos Wealth Advisors first reported a position in GILD in Q4 2018 and has held it in 19 quarters since. The position peaked at $667K in Q2 2021. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Stratos Wealth Advisors held 1,616 shares of Gilead Sciences worth $225K as of Q1 2026.
- Stratos Wealth Advisors sold 50 Gilead Sciences shares in Q1 2026, an estimated $7K.
- Gilead Sciences made up 0.01% of Stratos Wealth Advisors's portfolio in Q1 2026, its #557 holding.
- Stratos Wealth Advisors first reported a position in Gilead Sciences in Q4 2018 and has held it in 19 quarters since.
- Stratos Wealth Advisors's Gilead Sciences position peaked at $667K in Q2 2021.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Stratos Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.